News

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...

Braeburn Pharmaceutical asserts completion of its $110- million mezzanine financing among a few others like Avista Capital Partners, RA Capital Management, New Leaf Venture Partners,…
Read More...

Biodegradable balloon spacers, BioProtect announces the launch of Clinical Trial followed by the FDA approval for Investigational Device Exemption in November , 2017 that seeks to…
Read More...

AstraZeneca declared that BYDUREON BCise was now available in pharmacies across the U.S. An injectable suspension 2mg sanctioned by the U.S FDA for adults afflicted with Type-2 Diabetes…
Read More...

Artificial intelligence imaging and workflow software, Viz.ai announced CE Mark of its Direct-to-intervention system, ContaCT that adopts to interpret brain CTs intimating a specialist…
Read More...

Clinical stage biopharmaceutical company, SAB Biotherapeutics declared its phase 1 Clinical Trial results for treating MERS, a study that was undertaken by National Institutes of…
Read More...

Having forayed into development of minimally invasive solutions for symptomatic uterine fibroids, women’s healthcare company, Gynesonics announced the results for their pivotal IDE…
Read More...

The developer of a rapid point-of-care diagnostics tests, DCN Dx declared the appointment of John L. Tokinson, Ph.D. as its Chief business development Officer, welcoming him on board.…
Read More...

Omron Healthcare introduces an over the counter medical device, Avail for effective drug-free pain relief as millions of Americans suffer from alarming chronic pain Avail is Omron's…
Read More...

Cofactor Genomics declared the results from a study undertaken by them and Fred Hutchinson Cancer Research Center slated for presentation at the Molecular Medicine Tri-Conference in…
Read More...

The network of independent health systems based out of Arkansas, Missouri and Texas collaborate with Vizient for comprehensive sourcing, improvement of performance as well as services…
Read More...

Clearbridge Biomedics announced successful registration of ClearCell® FX1 system, its target cell- enrichment device with the U.S FDA as a class I Medical device for to diagnose…
Read More...

Cepheid declared that clearance has been granted by US FDA 510 (K) waiving clinical laboratory improvement Amendments CLIA for Xpert Xpress Flu test. Performed in near-patient settings,…
Read More...

GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Global standard platform for genomic data, Wuxi NextCode announced partnering with Rhythm to develop and commercialize therapies aimed to treat rare genetic disorders of obesity. Rhythm…
Read More...

Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

NovoNordisk pilots an education and disposal program for Californian patients to purge sharp products to safely use the company’s medicines that are otherwise delivered by a syringe or…
Read More...

ESN group committed to natural skin care initiatives announced the rollout of its Ceramedx® brand of natural ceramide therapy products as a substitute for dry and sensitive skin. Earth…
Read More...

Bell Biosystems declared the results of their latest preclinical safety study at the Biotech Showcase in San Francisco. The study managed to comply with USP <151> pyrogenicity…
Read More...